Retraction
Pathologic Complete Response and Its Impact on Breast Cancer Recurrence and Patient’s Survival after Neoadjuvant Therapy: A Comprehensive Meta-Analysis
Paper Information
Record ID:
56604
Author(s):
Publication Date:
December 31, 2021
Retraction Date:
September 27, 2023
(2.1 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9781535Additional Notes:
See also: https://pubpeer.com/publications/755C4FDB3576FBAA589D971089B3F1
Citations (14)
14
Total Citations9
Post-Retraction(64.3%)
5
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
8
Within 1 year
0
After 2+ years
597
Days since retraction (latest)
Identifying factors predicting the response to neoadjuvant chemotherapy in breast carcinoma
Wiem Ben Makhlouf, Ons Boudawara, Wala Ben Kridis et al. (6 authors)
Research Square (Research Square)
Published: May 2025
597 days after retraction
Axillary management and long-term oncologic outcomes in breast cancer patients with clinical N1 disease treated with neoadjuvant chemotherapy
Courtney C. Sparger, Alexandra E Hernandez, Kristin E. Rojas et al. (10 authors)
World Journal of Surgical Oncology
Open Access
Published: Jul 2024
306 days after retraction
Predictive value of ultrasound doppler parameters in neoadjuvant chemotherapy response of breast cancer: Prospective comparison with magnetic resonance and mammography
Lívia Conz, Rodrigo Menezes Jales, Maíra Teixeira Dória et al. (8 authors)
PLoS ONE
Open Access
Published: Jun 2024
251 days after retraction
Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis
Nurul Wafiqah Saipol Bahrin, Siti Nur Idayu Matusin, Aklimah Mustapa et al. (6 authors)
Systematic Reviews
Open Access
Published: Apr 2024
3 citations
3 citations
190 days after retraction
Difference in Outcome between Luminal A, Luminal B in Early Stage Breast Cancer Retrospective Study
Ahmed Dowidar, Zeinab Abdeltwab, Samah Semary et al. (4 authors)
Egyptian Journal of Medical Research
Open Access
Published: Apr 2024
187 days after retraction
Improving drug response prediction via integrating gene relationships with deep learning
Pengyong Li, Zhengxiang Jiang, Tianxiao Liu et al. (6 authors)
Briefings in Bioinformatics
Open Access
Published: Mar 2024
8 citations
8 citations
176 days after retraction
Machine learning prediction of pathological complete response and overall survival of breast cancer patients in an underserved inner-city population
Kevin Dell’Aquila, Abhinav Vadlamani, Takouhie Maldjian et al. (11 authors)
Breast Cancer Research
Open Access
Published: Jan 2024
2 citations
2 citations
105 days after retraction
Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial
Kezhen Li, Jing Chen, Yingjie Hu et al. (27 authors)
The Lancet Oncology
Published: Dec 2023
43 citations
43 citations
65 days after retraction
Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: A systematic review and meta-analysis
Mas Rina Wati Haji Abdul Hamid, Nurul Wafiqah Saipol Bahrin, Siti Nur Idayu Matusin et al. (6 authors)
Research Square (Research Square)
Open Access
Published: Nov 2023
62 days after retraction
Predictive Value of Ultrasound Doppler Parameters in the Neoadjuvant Chemotherapy Response of Breast Cancer: Prospective Comparison with Magnetic Resonance and Mammography
Lívia Conz, Rodrigo Menezes Jales, Maíra Teixeira Dória et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Sep 2023
16 days before retraction
Predictors of successful neoadjuvant treatment in HER2‑positive breast cancer
Elli-Noora Hännikäinen, Johanna Mattson, Peeter Karihtala
Oncology Letters
Open Access
Published: Aug 2023
4 citations
4 citations
36 days before retraction
Risk Factors of Breast Cancer Recurrence in Pathologic Complete Response Achieved by Patients Following Neoadjuvant Chemotherapy
Joon Young Choi, Doyoun Woen, Sung Yoon Jang et al. (12 authors)
Unknown Journal
Open Access
Published: Mar 2023
182 days before retraction
Axillary Downstaging and the Impact of Clinical Axillary Status on Efficacy of Neoadjuvant Therapy for HER2-Positive Breast Cancer: A Network Meta-Analysis
Yunzhao Luo, Hongchuan Jiang, Chengjiang Liu et al. (4 authors)
Technology in Cancer Research & Treatment
Open Access
Published: Jan 2023
3 citations
3 citations
269 days before retraction
Retracted: Pathologic Complete Response and Its Impact on Breast Cancer Recurrence and Patient’s Survival after Neoadjuvant Therapy: A Comprehensive Meta‐Analysis
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine
Open Access
Published: Jan 2023
269 days before retraction
Quick Stats
Total Citations:
14
Years Since Retraction:
2.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025